Navigators aim to boost cancer treatment completion in underserved groups

NCT ID NCT07014618

Recruiting now Knowledge-focused Sponsor: University of Oklahoma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether patient navigators can help African American, Native American, and Hispanic patients complete their radiation therapy for breast or prostate cancer. About 420 participants will fill out surveys before and after treatment to identify barriers and measure the impact of navigation. The goal is to improve access and adherence to standard cancer care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: patient navigator program
What this could lead to: If successful, this could show that patient navigators improve radiation therapy completion rates for underrepresented groups, pointing toward better support programs.
What could go wrong: This is an observational study using surveys, not testing a new treatment. Results may not apply to other populations or settings, and completion rates may not change significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER PROSTATE CANCER

Contacts and locations

Locations

OU Health Stephenson Cancer Center
RECRUITING

Oklahoma City, Oklahoma, 73117, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.